☆ 4.5 Review

Review of the Clinical and Economic Burden of Antibody-Mediated Rejection in Renal Transplant Recipients

ADVANCES IN THERAPY (2016)

Get Full Text
Add to Collection

Journal

ADVANCES IN THERAPY
Volume 33, Issue 3, Pages 345-356

Publisher

SPRINGER
DOI: 10.1007/s12325-016-0292-y

Keywords

Burden; Cost; Graft rejection; Nephrology; Renal transplant

Categories

Medicine, Research & Experimental Pharmacology & Pharmacy

Funding

  1. Astellas Pharma EMEA Limited, Chertsey, UK
  2. Astellas Pharma EMEA Limited

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Funding: Astellas Pharma EMEA Limited.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.